mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.6 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.6 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.026 |
0.6 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.6 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |